Oral tizanidine, an α2-adrenoceptor agonist, reduces the minimum alveolar concentration of sevoflurane in human adults

Anesthesia and Analgesia

Volumn 95, Issue 2, 2002, Pages 393-396

  Wajima, Zen'ichiro ^a   Yoshikawa, Tatsusuke ^a,b,c   Ogura, Akira ^d   Imanaga, Kazuyuki ^a   Shiga, Toshiya ^a   Inoue, Tetsuo ^a   Ogawa, Ryo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Hakujikai Memorial Hospital   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DRUG DERIVATIVE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; SEVOFLURANE; TIZANIDINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INTERACTION; DRUG POTENTIATION; FEMALE; HUMAN; INHALATION ANESTHESIA; LUNG ALVEOLUS; MALE; METABOLISM; MIDDLE AGED; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; ANESTHESIA INDUCTION; CLINICAL ARTICLE; CONSCIOUSNESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; EYELID REFLEX; MINIMUM LUNG ALVEOLUS CONCENTRATION; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SKIN INCISION; VERBAL COMMUNICATION; VITAL CAPACITY;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; CLONIDINE; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; PREANESTHETIC MEDICATION; PULMONARY ALVEOLI; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0036072037     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000019430.35232.F6     Document Type: Article

References (23)

1. The effects of clonidine and tizanidine on responses of nociceptive neurons in nucleus ventralis posterolateralis of the cat thalamus
2. Effects of tizanidine, eperisone and afloqualone on feline dorsal horn neuronal responses to peripheral cutaneous noxious and innocuous stimuli
3. 2-adrenoceptors
4. Tizanidine for preanesthetic medication
5. Effects of oral alpha 2 adrenergic agonists, clonidine and tizanidine, on tetracaine spinal anesthesia
6. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role
7. Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients
8. Effects of rapid inhalation induction with sevoflurane-oxygen anesthesia on epidural pressure in humans
9. Induction of anesthesia with sevoflurane, nitrous oxide, and oxygen: A comparison of spontaneous ventilation and vital capacity rapid inhalation induction (VCRII) techniques
10. Quantal-response to variable experimentation: The up-and-down methods
11. The effects of clonidine premedication on sevoflurane requirements and anesthetic induction time
12. Reduction in standard MAC and MAC for intubation after clonidine premedication in children
13. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine
14. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years
15. Pharmacokinetics of orally administered tizanidine in healthy volunteers
16. Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis
17. Biological fate of sirdalud in animals and man
18. Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud®)
19. Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury
20. Tizanidine: Initial pharmacokinetic studies in patients with spasticity
21. Inhibitory effects of clonidine and tizanidine on release of substance-P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists
22. Effects of tizanidine on morphine physical dependence: Attenuation and intensification
23. Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia